Please wait
Healthcare · Medical Devices · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$52.4B
N/A
54.08
Current price
$91.04
+0.9% todayUpdated 6 min ago
Open
$89.98
Previous close
$90.21
Day range
$89.32 – $91.29
Volume
N/A
54.1x P/E
Awaiting filing
No current yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for EW, with its range and direction at a glance.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Investors usually follow EW for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 74/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$242M
TTM (2026-06-30)
ROE
9.2%
Return on equity
ROA
8.4%
Return on assets
Debt / equity
0.07
Lower is usually safer.
P/B ratio
4.93
Useful for book value support.
85/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
$95.91
Analyst view
Buy
Analyst target
$100.96
Forecast refresh
Updated 2h ago
Quality score
72
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+5.8% across the latest saved price window.
Volatility
Moderate
Beta is 0.85. Price sensitivity is broadly around the market range.
52-week position
78% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
N/A
Comparable volume data is not available.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
EW
Edwards Lifesciences Corporation
Price: $91.04
P/E: 54.08036
Yield: N/A
ABBV
AbbVie Inc.
Price: $257.36
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.49
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.69
P/E: 27.310226
Yield: 0.0%
Industry
Medical Devices
Employees
16000
Exchange
NYQ
Ticker
EW
